ASTM-F1905 Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity (Withdrawn 2011)

ASTM-F1905 - 1998 R03 EDITION - CANCELLED
Show Complete Document History

Document Center Inc. is an authorized dealer of ASTM standards.
The following bibliographic material is provided to assist you with your purchasing decision:


This practice covers the selection of tests for determining the propensity of materials used in medical devices to affect the immune system. That is, the foreign material introduced into the body may affect the humoral immune response (such as effect on specific immune response and on B cell numbers), the cell mediated response (such as response of T cells), the inflammatory factors, and complement (a series of proteins important for inflammation and the immune response). Covered in this practice are immunotoxicity and biocompatibility tests as well as immunologic tests, which shall be performed to determine the suitability of a material to be used in medical devices. The tests shall conform to the requirements specified.

Scope

1.1 This practice covers the introduction of foreign materials into the body that may have an impact on the immune system. One possible effect is that the immune system will be depressed or certain cell types may be affected. Immunotoxicity may be determined with blood and tissue samples from the animals used in the other biocompatibility test procedures such as implantation and blood contact test protocols. It is also possible to use these techniques with blood samples from human patients in a clinical trial. Any procedures with human subjects should follow the appropriate rules of the local institutional review board and the appropriate regulatory agencies. This document may serve as an annex to Practice F748.

1.2 The material may affect the humoral immune response, the cell mediated response, or both.

1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Keywords

B cells; biocompatibility; cell mediated immunity; complement; humoral immunity; immunotoxicity; T cells; ICS Number Code 11.100 (Laboratory medicine); 13.300 (Protection against dangerous goods); 19.020 (Test conditions and procedures in general)

To find similar documents by ASTM Volume:

13.01 (Medical and Surgical Materials and Devices)

To find similar documents by classification:

11.100 (Laboratory medicine)

13.300 (Protection against dangerous goods Including performance requirements for dangerous goods, their handling, storage, transportation, marking, labelling, etc. Nuclear fissile materials, see 27.120.30 Explosives, see 71.100.30)

19.020 (Test conditions and procedures in general)

This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

 

Customers who bought this document also bought:

ISTA-1A
Non-Simulation Integrity Performance Tests, Packaged-Products weighing 150 lb (68 kg) or Less

ASTM-D4169
Standard Practice for Performance Testing of Shipping Containers and Systems

ISO-10993-12
Biological evaluation of medical devices - Part 12: Sample preparation and reference materials

Document Number

ASTM-F1905-98(2003)

Revision Level

1998 R03 EDITION

Status

Cancelled

Modification Type

Withdrawn

Publication Date

Nov. 1, 2003

Document Type

Practice

Page Count

3 pages

Committee Number

F04.16